Tomio D Miyai, MD
Pulmonary Disease · Redwood City
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 5
- 2 carriers
- Offices
- 4
Offices
4 locations · Permanente Medical Group Inc · 10,928 clinicians in this group
Looking this up.
Hospitals listed: Kaiser Foundation Hospital - South San Francisco. That is not proof they admit you there this week.
Plans that list them
5 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Miyai’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
5 of 5 plans
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Kaiser Foundation Hospital - South San FranciscoSouth San Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Kaiser Permanente, which runs 41 hospitals in 3 statesPatients rate it 4 of 5 · 74% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Kaiser Foundation Hospital - South San Francisco
Behind the star rating — Deaths: 0 better, 1 the same, 0 worse of 1 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 1 the same, 0 worse of 1 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.04 (0 to 2.12) · 89 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.97 (0.49 to 1.46) | No different | Jul 2022 – Jun 2024 |
| Death rate for stroke patientsComplications and deaths | 14.3 · 195 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 1,992 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 562 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.1 to 0.53) · 589 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.37 (0.77 to 5.96) · 64 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.39) · 26 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.31 (0.58 to 4.04) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.99 (0 to 18.96) · 27 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.49 (0 to 1.68) · 433 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.1 · 108 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.772 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.867 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.9 · 75 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.4 · 520 cases | None | Jul 2023 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 21.2 · 562 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21 · 149 cases | None | Jul 2023 – Jun 2025 |
What patients said (553 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 73% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 39% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$2,622
Medicare paid this office $2,622 for 16 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
16 Original Medicare patients in 2024. Average age 69 · 85 and older 0% · Health risk score 1.46. At or below the middle of the specialty; the typical pulmonary disease clinician is at 2.13.
Conditions among them: High blood pressure 75%.
The office billed $5,947, Medicare allowed $3,279 and paid $2,622; for 32 services of 10 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 16 | 32 | 69 | 1.46 | $5,947 | $2,622 |
| 2023 | 11 | 34 | 69 | 2.81 | $6,689 | $2,946 |
| 2022 | 12 | 23 | 68 | 1.59 | $4,453 | $1,300 |
| 2021 | 11 | 20 | 64 | 2.90 | $3,230 | $1,268 |
| 2019 | 14 | 23 | 68 | 2.09 | $4,536 | $1,534 |
| 2018 | 12 | 25 | 72 | 3.03 | $4,549 | $1,452 |
| 2017 | 11 | 15 | 65 | 1.01 | $2,546 | $670 |
| 2016 | 13 | 30 | 72 | 2.83 | $6,372 | $1,824 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2019: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $1,030 | $64 |
2016: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $1,639 | $63 |
Drugs they prescribed that Part D paid
$182,250
Pharmacies billed $182,250 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 574) in 2024. At or below the middle of the specialty; the typical pulmonary disease clinician is at 0%.
293 generic and 281 brand-name prescriptions · $182,250 in drug cost · 66 antibiotic prescriptions to 38 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Spiriva Respimat | 82 | $65,441 | $798 |
| Stiolto Respimat | 24 | $21,870 | $911 |
| Wixela Inhub | 62 | $18,651 | $301 |
| Alvesco | 48 | $7,615 | $159 |
| Advair Hfa | 11 | $6,556 | $596 |
See all 11 drugs
| Spiriva Respimat | 82 | $65,441 | $798 |
| Stiolto Respimat | 24 | $21,870 | $911 |
| Wixela Inhub | 62 | $18,651 | $301 |
| Alvesco | 48 | $7,615 | $159 |
| Advair Hfa | 11 | $6,556 | $596 |
| Albuterol Sulfate Hfa | 98 | $2,039 | $21 |
| Prednisone | 58 | $778 | $13 |
| Fluticasone Propionate | 33 | $700 | $21 |
| Montelukast | 28 | $308 | $11 |
| Azithromycin | 20 | $254 | $13 |
| Sulfamethoxazole-Trimethoprim | 19 | $143 | $8 |
Year by year
| 2024 | 574 | 128 | 0% (0) | 49% | $182,250 |
| 2023 | 655 | 134 | None | None | $213,114 |
| 2022 | 626 | 123 | None | 52% | $161,653 |
| 2021 | 658 | 128 | 0% (0) | 49% | $156,223 |
| 2020 | 678 | 116 | None | 74% | $166,739 |
| 2019 | 719 | 118 | None | 68% | $218,491 |
| 2018 | 794 | 127 | None | 73% | $294,788 |
| 2017 | 795 | 136 | None | 72% | $163,540 |
| 2016 | 590 | 121 | None | 70% | $131,310 |
| 2015 | 306 | 103 | 0% (0) | 69% | $72,067 |
| 2014 | 96 | 38 | 0% (0) | 65% | $14,429 |
| 2013 | 28 | None | 0% (0) | 64% | $6,865 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 15 drugs
| Spiriva Respimat | 101 | $75,133 | $744 |
| Wixela Inhub | 92 | $24,166 | $263 |
| Dulera | 14 | $12,101 | $864 |
| Stiolto Respimat | 13 | $11,714 | $901 |
| Alvesco | 47 | $8,051 | $171 |
| Advair Hfa | 22 | $7,742 | $352 |
| Symbicort | 17 | $6,357 | $374 |
| Albuterol Sulfate Hfa | 102 | $2,324 | $23 |
| Mycophenolate Mofetil | 12 | $1,855 | $155 |
| Prednisone | 61 | $910 | $15 |
| Fluticasone Propionate | 37 | $509 | $14 |
| Cefpodoxime Proxetil | 13 | $493 | $38 |
| Azithromycin | 24 | $222 | $9 |
| Montelukast | 20 | $220 | $11 |
| Sulfamethoxazole-Trimethoprim | 15 | $118 | $8 |
2022: 13 drugs
| Spiriva Respimat | 115 | $78,865 | $686 |
| Wixela Inhub | 109 | $27,122 | $249 |
| Dulera | 11 | $10,199 | $927 |
| Advair Hfa | 28 | $9,954 | $356 |
| Stiolto Respimat | 11 | $9,407 | $855 |
| Alvesco | 45 | $7,787 | $173 |
| Mycophenolate Mofetil | 19 | $2,964 | $156 |
| Albuterol Sulfate Hfa | 88 | $1,762 | $20 |
| Prednisone | 49 | $596 | $12 |
| Fluticasone Propionate | 28 | $370 | $13 |
| Azithromycin | 24 | $252 | $10 |
| Montelukast | 21 | $231 | $11 |
| Sulfamethoxazole-Trimethoprim | 11 | $103 | $9 |
2021: 14 drugs
| Spiriva Respimat | 125 | $77,909 | $623 |
| Wixela Inhub | 135 | $31,115 | $230 |
| Stiolto Respimat | 12 | $10,116 | $843 |
| Alvesco | 45 | $8,958 | $199 |
| Advair Hfa | 16 | $6,400 | $400 |
| Mycophenolate Mofetil | 20 | $3,414 | $171 |
| Albuterol Sulfate Hfa | 82 | $1,927 | $23 |
| Ventolin Hfa | 18 | $1,152 | $64 |
| Prednisone | 55 | $893 | $16 |
| Cefpodoxime Proxetil | 13 | $506 | $39 |
| Montelukast | 34 | $353 | $10 |
| Azithromycin | 27 | $276 | $10 |
| Fluticasone Propionate | 19 | $238 | $13 |
| Sulfamethoxazole-Trimethoprim | 15 | $127 | $8 |
2020: 15 drugs
| Spiriva Respimat | 117 | $63,306 | $541 |
| Advair Diskus | 167 | $45,288 | $271 |
| Dulera | 17 | $12,927 | $760 |
| Advair Hfa | 20 | $10,783 | $539 |
| Alvesco | 63 | $8,357 | $133 |
| Ventolin Hfa | 74 | $4,083 | $55 |
| Flovent Hfa | 11 | $3,188 | $290 |
| Mycophenolate Mofetil | 13 | $2,405 | $185 |
| Proair Hfa | 14 | $938 | $67 |
| Prednisone | 44 | $932 | $21 |
| Albuterol Sulfate Hfa | 12 | $792 | $66 |
| Montelukast | 29 | $338 | $12 |
| Fluticasone Propionate | 19 | $238 | $13 |
| Sulfamethoxazole-Trimethoprim | 17 | $140 | $8 |
| Azithromycin | 12 | $124 | $10 |
2019: 13 drugs
| Spiriva Respimat | 108 | $65,319 | $605 |
| Advair Diskus | 141 | $57,526 | $408 |
| Advair Hfa | 26 | $17,185 | $661 |
| Dulera | 19 | $12,309 | $648 |
| Ventolin Hfa | 111 | $7,182 | $65 |
| Alvesco | 38 | $4,609 | $121 |
| Mycophenolate Mofetil | 12 | $2,838 | $236 |
| Prednisone | 66 | $977 | $15 |
| Montelukast | 34 | $437 | $13 |
| Fluticasone Propionate | 32 | $426 | $13 |
| Cefpodoxime Proxetil | 12 | $423 | $35 |
| Azithromycin | 35 | $387 | $11 |
| Sulfamethoxazole-Trimethoprim | 11 | $89 | $8 |
2018: 13 drugs
| Spiriva Respimat | 133 | $71,434 | $537 |
| Advair Diskus | 169 | $64,972 | $384 |
| Advair Hfa | 30 | $20,074 | $669 |
| Dulera | 31 | $16,270 | $525 |
| Stiolto Respimat | 11 | $9,255 | $841 |
| Ventolin Hfa | 141 | $7,617 | $54 |
| Qvar | 24 | $4,077 | $170 |
| Mycophenolate Mofetil | 12 | $3,574 | $298 |
| Prednisone | 58 | $863 | $15 |
| Azithromycin | 27 | $554 | $21 |
| Fluticasone Propionate | 40 | $510 | $13 |
| Montelukast | 28 | $491 | $18 |
| Sulfamethoxazole-Trimethoprim | 12 | $128 | $11 |
2017: 9 drugs
| Spiriva Respimat | 155 | $72,702 | $469 |
| Dulera | 170 | $39,797 | $234 |
| Advair Diskus | 52 | $15,908 | $306 |
| Ventolin Hfa | 134 | $6,388 | $48 |
| Qvar | 27 | $3,357 | $124 |
| Prednisone | 53 | $943 | $18 |
| Montelukast | 28 | $640 | $23 |
| Fluticasone Propionate | 40 | $539 | $13 |
| Azithromycin | 25 | $357 | $14 |
2016: 10 drugs
| Spiriva Respimat | 147 | $56,126 | $382 |
| Dulera | 137 | $25,855 | $189 |
| Combivent Respimat | 11 | $10,120 | $920 |
| Ventolin Hfa | 54 | $2,433 | $45 |
| Qvar | 17 | $1,682 | $99 |
| Proair Hfa | 31 | $1,046 | $34 |
| Prednisone | 34 | $678 | $20 |
| Fluticasone Propionate | 33 | $451 | $14 |
| Montelukast | 17 | $442 | $26 |
| Azithromycin | 17 | $153 | $9 |
2015: 6 drugs
| Spiriva | 58 | $29,566 | $510 |
| Dulera | 60 | $19,076 | $318 |
| Spiriva Respimat | 18 | $6,177 | $343 |
| Proair Hfa | 52 | $1,800 | $35 |
| Prednisone | 29 | $464 | $16 |
| Fluticasone Propionate | 12 | $214 | $18 |
2014: 4 drugs
| Spiriva | 23 | $6,772 | $294 |
| Dulera | 15 | $3,167 | $211 |
| Proair Hfa | 14 | $576 | $41 |
| Fluticasone Propionate | 12 | $292 | $24 |
Professional record
- NPI
- 1770731978
- Trained
- University of California, Davis School of Medicine, 2007
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Student in a training program (390200000X)
- Mailing address
- 751 S Bascom Ave, Department of Internal Medicine, San Jose, CA, 95128
- NPI first listed
- 2008-09-03
- NPI last updated
- 2021-12-22
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.